<DOC>
	<DOCNO>NCT01077024</DOCNO>
	<brief_summary>The primary objective study evaluate impact substance-abuse treatment usual plus smoking-cessation treatment ( TAU+SCT ) , relative substance-abuse treatment usual ( TAU ) , drug-abuse outcome . Specifically , study evaluate whether concurrent smoking-cessation treatment improve , worsens , effect stimulant-use outcomes smoker outpatient substance-abuse treatment cocaine methamphetamine dependence .</brief_summary>
	<brief_title>Smoking-Cessation Stimulant Treatment ( S-CAST )</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Clinical diagnosis cocaine/methamphetamine dependence Smoked cigarettes least 3 month Currently smoke &gt; 6 cigarettes/day Have interest quit smoke Enrolled outpatient treatment participate site Clinical diagnosis current alcohol sedative dependence , bipolar disorder ; lifetime diagnosis anorexia nervosa bulimia Seeking/receiving treatment opiateagonist replacement therapy Medical condition could compromise participant safety Taking medication known/potential interaction bupropion Hypersensitivity bupropion , nicotine , menthol Pregnant breastfeeding Abnormal ECG Recent smoke cessation treatment Use tobacco product cigarette past week Likely enter residential/inpatient treatment within 10 week Have stimulantpositive urine drug screen screening/baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Stimulant treatment</keyword>
	<keyword>Smoking Cessation</keyword>
</DOC>